Fundraising FoxOraya Therapeutics
Newark, US
Find your way into Oraya Therapeutics
Sign up to see every warm intro you have to Oraya Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oraya Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
BH
Brian HalakBoard director
MB
Mark BrooksBoard director
GN
Guido NeelsBoard director
RZ
Reza ZadnoBoard director
Reported raises · per SEC filings
Form D private placements$25.1M disclosed across 1 round · 2014
▶$25.1MraisedMay 2014 · 5 investors · Other TechnologyRule 506(b)
▶$25.1MraisedMay 2014 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Peter CohnExecutive Officer
- Brian HalakDirector
- Reza ZadnoDirector
- Mark BrooksDirector
- James TaylorExecutive Officer, Director
- Michael GertnerDirector
- Guido NeelsDirector
- Offering amount
- $38.2M
- Amount sold
- $25.1M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Oraya Therapeutics?
- Oraya Therapeutics was founded by Michael Gertner.
- How much funding has Oraya Therapeutics raised?
- Oraya Therapeutics has disclosed $25.1M raised across 1 round.
- Where is Oraya Therapeutics headquartered?
- Oraya Therapeutics is headquartered in Newark, US.